Nurse Practitioner in Ninety Six, SC Accepting Medicare
1 Nurse Practitioner nurses found. Showing 1 - 1
 Patricia M Vaughn-goodman, APRN Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 103 Little Mountain Rd, Ninety Six, SC 29666 Phone: 864-543-3515 Fax: 864-543-2973 |
News Archive
Seniors play powerful role in today's elections
The Christian Science Monitor: "Seniors and baby boomers are more engaged in the election and more excited about voting than any preelection polling has found since 1994, according to the Pew Research Center. While it was considered to be youth that ushered in the Obama revolution, it is the older generation that is wielding more power now.
New report explores strategies involved in developing and commercializing FDC products
Fixed dose combination (FDC) products, which have been around for many years, can have both clinical and commercial advantages. Successful FDC products require thoughtful planning, beginning early in the product development and lifecycle management processes.
Positive social support from adult children linked to reduced dementia risk
Positive social support from adult children is associated with reduced risk of developing dementia, according to a new research published today.
FDA accepts Teva Pharmaceutical's sNDA for COPAXONE
Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration has accepted for review the company's supplemental new drug application for COPAXONE (glatiramer acetate injection) 40mg/ 1mL, a higher concentration dose of COPAXONE that offers a less frequent three times a week dosing regimen administered subcutaneously for patients with relapsing-remitting multiple sclerosis.
Response Genetics, GSK sign non-exclusive license agreement for BRAF mutational analysis technology
Response Genetics, Inc., a company focused on the development and sale of molecular diagnostic tests for cancer, today announced it has signed a non-exclusive license agreement with GlaxoSmithKline ("GSK"). Under the terms of the agreement, GSK gains certain rights to Response Genetics' proprietary PCR analysis technology and diagnostic expertise to assess BRAF gene mutations in human tumor samples. Payments will be made to Response Genetics upon achivement of agreed-to milestones.
› Verified 7 days ago